8-KFiled Aug 12, 8:00 PM ET

Vivani Medical Reports Q2 2026 Financial Results, Business Update

$VANI · Vivani Medical, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Vivani Medical Reports Q2 2026 Financial Results, Business Update

What Happened

  • Vivani Medical, Inc. filed a Form 8‑K on August 13, 2026 announcing its second quarter 2026 financial results via a press release titled “Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update” (attached as Exhibit 99.1).
  • The company also disclosed a corporate slide presentation used with investors and at conferences (attached as Exhibit 99.2) and is posting that slide deck to the Investors section of its website. The slides are presented as of the 8‑K date and the company disclaims any obligation to update them later.

Key Details

  • Filing date: August 13, 2026 (Form 8‑K).
  • Press release attached as Exhibit 99.1; slide presentation attached as Exhibit 99.2.
  • Slide deck is being posted on Vivani’s Investors webpage and may be used at industry investor conferences.
  • The company made a Regulation FD disclosure by distributing these materials publicly; slides “speak as of” the 8‑K date and may not be updated.

Why It Matters

  • The press release is the company’s official public report of its Q2 2026 quarterly results; investors should review the press release and slide deck for revenue, earnings, cash position, and any operational updates or guidance.
  • Posting the slide deck and making a Regulation FD disclosure ensures the information is broadly available to the market at the same time, which can affect investor sentiment and the stock price.
  • Because the 8‑K attaches the materials but does not itself detail financial figures in the filing text, investors should read Exhibit 99.1 (press release) for the specific quarterly numbers and management commentary.